Olga Frankfurt Selected Research

MDS1 and EVI1 Complex Locus Protein

1/2022

Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olga Frankfurt Research Topics

Disease

18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 11/2007
7	Neoplasms (Cancer) 01/2022 - 07/2014
5	Leukemia 01/2022 - 11/2004
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 03/2012
3	Hematologic Neoplasms (Hematological Malignancy) 09/2009 - 11/2004
2	Febrile Neutropenia 01/2022 - 11/2014
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2021 - 12/2013
2	Neutropenia 10/2021 - 02/2007
2	Infections 10/2021 - 02/2007
2	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 06/2014
2	Hemorrhage 01/2018 - 09/2013
2	Anemia 01/2018 - 01/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014 - 11/2013
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021
1	Fibrosis (Cirrhosis) 08/2019
1	Primary Myelofibrosis (Myelosclerosis) 08/2019
1	Splenomegaly 08/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2019
1	Histiocytic Sarcoma 03/2019
1	Pancreatitis 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Critical Illness (Critically Ill) 11/2014
1	Anterior Uveitis 08/2014
1	Drug Eruptions (Drug Eruption) 12/2013
1	Folliculitis (Sycosis) 12/2013
1	Erythema 12/2013
1	Exanthema (Rash) 12/2013
1	Acute Promyelocytic Leukemia 09/2013
1	Disseminated Intravascular Coagulation 03/2009
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2008
1	Mycoses (Diseases, Fungus) 04/2007
1	Bone Marrow Failure Disorders 02/2007
1	Lymphoma (Lymphomas) 11/2004

Drug/Important Bio-Agent (IBA)

3	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2021 - 04/2012
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2014
3	Rituximab (Mabthera)FDA Link 01/2019 - 02/2008
3	Pharmaceutical PreparationsIBA 01/2018 - 02/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 11/2014
2	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2021 - 04/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021 - 02/2007
2	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 01/2019
2	fms-Like Tyrosine Kinase 3IBA 01/2020 - 12/2013
2	Alemtuzumab (Campath)FDA Link 01/2019 - 02/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 08/2013
2	Etoposide (VP 16)FDA LinkGeneric 08/2013 - 04/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011 - 02/2007
1	enasidenibIBA 06/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	gilteritinibIBA 01/2022
1	MDS1 and EVI1 Complex Locus ProteinIBA 01/2022
1	selinexorIBA 12/2021
1	alvocidib (flavopiridol)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2021
1	Calcineurin InhibitorsIBA 10/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	EnzymesIBA 01/2021
1	ivosidenibIBA 01/2021
1	pexidartinibIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	MLN 8237IBA 08/2019
1	Aurora Kinase AIBA 08/2019
1	CytokinesIBA 08/2019
1	ruxolitinibIBA 08/2019
1	serum P-component (CIt)IBA 01/2019
1	venetoclaxIBA 01/2019
1	Pentostatin (Nipent)FDA LinkGeneric 01/2019
1	Decitabine FDA Link 01/2019
1	quizartinibIBA 01/2018
1	blinatumomabIBA 01/2018
1	Hydroxyurea (Hydrea)FDA LinkGeneric 03/2015
1	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 07/2014
1	tagraxofuspIBA 07/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2014
1	Mechanistic Target of Rapamycin Complex 2IBA 05/2014
1	Ivermectin (Mectizan)FDA Link 12/2013
1	SteroidsIBA 12/2013
1	ponatinibIBA 11/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2013
1	Lipocalin-2IBA 08/2013
1	Lenalidomide (CC 5013)FDA Link 03/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2009
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2009
1	Dacarbazine (DIC)FDA LinkGeneric 03/2009
1	Voriconazole (Vfend)FDA LinkGeneric 04/2007
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2007
1	GlucocorticoidsIBA 11/2004

Therapy/Procedure

14	Therapeutics 06/2022 - 04/2007
7	Drug Therapy (Chemotherapy) 01/2019 - 02/2007
5	Stem Cell Transplantation 03/2019 - 08/2013
2	Lymphatic Irradiation 01/2019 - 06/2014
1	Induction Chemotherapy 10/2021
1	Cell Transplantation 01/2017
1	Transplantation 09/2009